A 24-week study to evaluate the effectiveness of valsartan in combination with hydrochlorothiazide versus amlodipine on arterial compliance in patients with hypertension, type 2 diabetes and albuminuria
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Amlodipine; Valsartan/hydrochlorothiazide
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual patient number is 144 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (September 2006) added as reported by ClinicalTrials.gov.
- 08 Jan 2007 Status change